Shelly Soni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shelly Soni has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Julie S. Moldenhauer
15 shared publicationsNahla Khalek
Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Children's Hospital of Philadelphia Philadelphia Pennsylvania USA
15 shared publicationsChristina Paidas Teefey
11 shared publicationsJuliana S. Gebb
8 shared publications- Juliana Gebb
Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Children's Hospital of Philadelphia Philadelphia Pennsylvania USA
6 shared publications N. Scott Adzick
5 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (12) , 1871-1878
Diagnostic Yield of Sequencing in Prenatal Agenesis of the Corpus Callosum in a Well‐Phenotyped International Cohort
Objective: To evaluate the incremental diagnostic yield of sequencing in a large, well‐phenotyped international cohort of fetuses with prenatally diagnosed agenesis of the corpus callosum (ACC) and to identify associated genes and variants. Methods: Retrospective multicenter cohort study of fetuses with a prenatal diagnosis of ACC undergoing sequencing after nondiagnostic chromosomal microarray. Clinical data were obtained from prenatal ultrasound and fetal MRI reports. Cases were classified as isolated ACC, ACC with additional central nervous system (CNS) abnormalities, or ACC with extracranial abnormalities. Variants were classified according to the ACMG or ACGS criteria. Results: Among 321 fetuses with ACC, a pathogenic or likely pathogenic (P/LP) variant was identified in 97 cases (30.2%). Diagnostic yield increased with phenotypic complexity: 17.3% in isolated ACC, 25.7% in ACC with additional CNS abnormalities, and 41.0% in ACC with extracranial abnormalities. MRI confirmation was available in 249 cases (77.6%) and did not alter overall diagnostic yield of genetic testing. No significant difference in yield was observed between complete ACC and other ACC types. P/LP variants were identified in 51 genes, most frequently TUBA1A . Conclusion: Sequencing provides substantial diagnostic yield in prenatally diagnosed ACC, particularly when additional CNS or extracranial anomalies are present. These findings support the use of exome or genome sequencing in the prenatal evaluation of ACC and emphasize the importance of detailed phenotyping to improve classification, interpretation and counseling.
- 25 September 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (12) , 1871-1878
Open AccessDiagnostic Yield of Sequencing in Prenatal Agenesis of the Corpus Callosum in a Well‐Phenotyped International Cohort
Objective: To evaluate the incremental diagnostic yield of sequencing in a large, well‐phenotyped international cohort of fetuses with prenatally diagnosed agenesis of the corpus callosum (ACC) and to identify associated genes and variants. Methods: Retrospective multicenter cohort study of fetuses with a prenatal diagnosis of ACC undergoing sequencing after nondiagnostic chromosomal microarray. Clinical data were obtained from prenatal ultrasound and fetal MRI reports. Cases were classified as isolated ACC, ACC with additional central nervous system (CNS) abnormalities, or ACC with extracranial abnormalities. Variants were classified according to the ACMG or ACGS criteria. Results: Among 321 fetuses with ACC, a pathogenic or likely pathogenic (P/LP) variant was identified in 97 cases (30.2%). Diagnostic yield increased with phenotypic complexity: 17.3% in isolated ACC, 25.7% in ACC with additional CNS abnormalities, and 41.0% in ACC with extracranial abnormalities. MRI confirmation was available in 249 cases (77.6%) and did not alter overall diagnostic yield of genetic testing. No significant difference in yield was observed between complete ACC and other ACC types. P/LP variants were identified in 51 genes, most frequently TUBA1A . Conclusion: Sequencing provides substantial diagnostic yield in prenatally diagnosed ACC, particularly when additional CNS or extracranial anomalies are present. These findings support the use of exome or genome sequencing in the prenatal evaluation of ACC and emphasize the importance of detailed phenotyping to improve classification, interpretation and counseling.
- Open Access
Characteristics and outcomes of monochorionic diamniotic twin pregnancies complicated by selective fetal growth restriction with intermittent absent end diastolic flow
Introduction: Monochorionic diamniotic twins with selective fetal growth restriction (sFGR) are categorized based on the umbilical artery (UA) end diastolic flow (EDF) of the growth‐restricted fetus. While persistent flow abnormalities are attributed to placental insufficiency, intermittent flow changes are often attributed to anastomoses. We hypothesized that not all intermittent flow is due to anastomotic fluctuation and sought to determine if pregnancies with intermittent forward and absent EDF may represent a unique cohort of sFGR pregnancy. Methods: Retrospective analysis of prospectively collected data from a monochorionic pregnancy registry. Records of patients with monochorionic diamniotic twins with sFGR evaluated from January 2013 to December 2024 were reviewed. sFGR was defined by the Delphi‐based consensus criteria. Pregnancies were grouped by the umbilical artery Doppler of the smaller fetus: (1) Type I: persistent forward EDF (+EDF); (2) Type II: no forward EDF (A/REDF); (3) Type IIIa: intermittent forward and absent EDF (iAEDF); or (4) Type IIIb: intermittent forward, absent, and reversed EDF (iAREDF). Pregnancy characteristics were compared between groups and outcomes were then compared in expectantly managed patients. Results: Of 330 patients with sFGR, 114 (34.5%) had +EDF (Type I), 70 (21.2%) had A/REDF (Type II), 90 (27.3%) had iAEDF (Type IIIa), and 56 (17.0%) had iAREDF (Type IIIb). Gestational age at first evaluation was lower in those with Type II compared to Type IIIb ( p = 0.003) and fetal intervention was higher in patients with any absent or reversed EDF compared to those with +EDF ( p < 0.001). In expectantly managed patients ( n = 189), median gestational age at delivery in weeks was higher in patients with Type I (32.5) and Type IIIa (32.4) compared to those with Type II (27.4) and Type IIIb (29.1) (Type I vs. Type II, p < 0.001; Type I vs. Type IIIa, p = 0.319; Type I vs. Type IIIb, p < 0.001; Type II vs. Type IIIa, p = 0.003; Type II vs. Type IIIb, p = 0.598; Type IIIa vs. Type IIIb, p < 0.001). Additionally, dual survival to discharge was higher in those with Type I compared to Type II ( p < 0.001) but not compared to Type IIIa ( p = 0.292) or Type IIIb ( p = 0.262). Conclusion: Patients with sFGR and intermittent absent EDF may represent a unique cohort with outcomes more similar to those with +EDF than those with intermittent forward, absent, and reversed EDF.
Open AccessCharacteristics and outcomes of monochorionic diamniotic twin pregnancies complicated by selective fetal growth restriction with intermittent absent end diastolic flow
Introduction: Monochorionic diamniotic twins with selective fetal growth restriction (sFGR) are categorized based on the umbilical artery (UA) end diastolic flow (EDF) of the growth‐restricted fetus. While persistent flow abnormalities are attributed to placental insufficiency, intermittent flow changes are often attributed to anastomoses. We hypothesized that not all intermittent flow is due to anastomotic fluctuation and sought to determine if pregnancies with intermittent forward and absent EDF may represent a unique cohort of sFGR pregnancy. Methods: Retrospective analysis of prospectively collected data from a monochorionic pregnancy registry. Records of patients with monochorionic diamniotic twins with sFGR evaluated from January 2013 to December 2024 were reviewed. sFGR was defined by the Delphi‐based consensus criteria. Pregnancies were grouped by the umbilical artery Doppler of the smaller fetus: (1) Type I: persistent forward EDF (+EDF); (2) Type II: no forward EDF (A/REDF); (3) Type IIIa: intermittent forward and absent EDF (iAEDF); or (4) Type IIIb: intermittent forward, absent, and reversed EDF (iAREDF). Pregnancy characteristics were compared between groups and outcomes were then compared in expectantly managed patients. Results: Of 330 patients with sFGR, 114 (34.5%) had +EDF (Type I), 70 (21.2%) had A/REDF (Type II), 90 (27.3%) had iAEDF (Type IIIa), and 56 (17.0%) had iAREDF (Type IIIb). Gestational age at first evaluation was lower in those with Type II compared to Type IIIb ( p = 0.003) and fetal intervention was higher in patients with any absent or reversed EDF compared to those with +EDF ( p < 0.001). In expectantly managed patients ( n = 189), median gestational age at delivery in weeks was higher in patients with Type I (32.5) and Type IIIa (32.4) compared to those with Type II (27.4) and Type IIIb (29.1) (Type I vs. Type II, p < 0.001; Type I vs. Type IIIa, p = 0.319; Type I vs. Type IIIb, p < 0.001; Type II vs. Type IIIa, p = 0.003; Type II vs. Type IIIb, p = 0.598; Type IIIa vs. Type IIIb, p < 0.001). Additionally, dual survival to discharge was higher in those with Type I compared to Type II ( p < 0.001) but not compared to Type IIIa ( p = 0.292) or Type IIIb ( p = 0.262). Conclusion: Patients with sFGR and intermittent absent EDF may represent a unique cohort with outcomes more similar to those with +EDF than those with intermittent forward, absent, and reversed EDF.
- Open Access
- 3 August 2026
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- p. 1-8
Perinatal Mood and Anxiety in Women Undergoing Open Maternal-Fetal Surgery for Myelomeningocele Closure
Introduction: Pregnant people carrying fetuses with congenital anomalies are at increased risk for perinatal mood and anxiety disorders (PMADs). Limited data exist regarding the impact of maternal-fetal surgery on maternal mental health. This study aimed to evaluate PMAD symptoms in pregnant people who opted for open maternal-fetal surgery (OMFS) for spina bifida (fMMC) closure. Methods: This was a retrospective cohort study of patients who underwent OMFS for fMMC closure at a level III fetal center. The Postpartum Depression Screening Scale (PDSS) and Impact of Event Scale-Revised (IES-R) were administered at initial evaluation and 1 day post-birth. Demographics, perioperative factors, surgical and delivery outcomes, and type of psychosocial support interactions were collected. Results: Of 171 pregnant people who underwent OMFS, 91 (50.8%) screened positive for depressive symptoms and 27 (15.1%) for anxiety/traumatic stress at the initial evaluation, prior to OMFS. After delivery, 45 (25.1%) screened positive for depressive symptoms and 2 (0.01%) for anxiety/traumatic stress symptoms. There was a statistically significant decrease in positive screen rates in the postpartum period for depressive and anxiety/traumatic stress (p < 0.001). Conclusions: Women undergoing OMFS for fMMC closure are at a high risk for PMAD symptoms in the perinatal period. Routine mental health screening in pregnancy and integrated psychosocial support are essential in caring for this unique population.
- 3 August 2026
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- p. 1-8
Open AccessPerinatal Mood and Anxiety in Women Undergoing Open Maternal-Fetal Surgery for Myelomeningocele Closure
Introduction: Pregnant people carrying fetuses with congenital anomalies are at increased risk for perinatal mood and anxiety disorders (PMADs). Limited data exist regarding the impact of maternal-fetal surgery on maternal mental health. This study aimed to evaluate PMAD symptoms in pregnant people who opted for open maternal-fetal surgery (OMFS) for spina bifida (fMMC) closure. Methods: This was a retrospective cohort study of patients who underwent OMFS for fMMC closure at a level III fetal center. The Postpartum Depression Screening Scale (PDSS) and Impact of Event Scale-Revised (IES-R) were administered at initial evaluation and 1 day post-birth. Demographics, perioperative factors, surgical and delivery outcomes, and type of psychosocial support interactions were collected. Results: Of 171 pregnant people who underwent OMFS, 91 (50.8%) screened positive for depressive symptoms and 27 (15.1%) for anxiety/traumatic stress at the initial evaluation, prior to OMFS. After delivery, 45 (25.1%) screened positive for depressive symptoms and 2 (0.01%) for anxiety/traumatic stress symptoms. There was a statistically significant decrease in positive screen rates in the postpartum period for depressive and anxiety/traumatic stress (p < 0.001). Conclusions: Women undergoing OMFS for fMMC closure are at a high risk for PMAD symptoms in the perinatal period. Routine mental health screening in pregnancy and integrated psychosocial support are essential in caring for this unique population.
- Open Access
- 22 January 2026
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 53 (4) , 1-8
Maternal Subcutaneous Seroma following Open Maternal Fetal Surgery for Closure of Fetal Open Neural Tube Defects
Introduction: Maternal seroma has been noted following open maternal fetal surgery (OMFS) for fetal neural tube defect (fNTD) closure but the risk factors, timing of diagnosis, natural course, and clinical significance have not been reported. Methods: Retrospective review of 340 patients who underwent OMFS for fNTD at a single center. Archived postoperative ultrasound images were reviewed and seroma details on serial ultrasound imaging were recorded. Perioperative characteristics and delivery outcomes were then compared in patients that did or did not develop a maternal seroma after OMFS. Multivariable logistic regression was performed to identify risk factors for seroma formation. Results: Of 330 patients with ongoing pregnancies at least 10 days after OMFS, 122 (37%) patients had sonographic evidence of seroma. Median postoperative day at diagnosis was 11 with median time to resolution of 21 days. Median longest diameter at diagnosis was 5.23 cm with a median initial volume of 9.66 mL. Seromas minimally increased in size prior to resolution. Multivariable logistic regression identified increasing maternal age and body mass index (BMI) as statistically significant risk factors for seroma formation (OR 1.08 and 1.17, respectively). There was no difference in the incidence of post-OMFS complications in those who developed seroma and those who did not, including no difference in the rate of membrane separation, oligohydramnios, preterm premature rupture of membranes, placental abruption, preterm labor, gestational age at delivery, fetal demise, or hysterotomy dehiscence. Following cesarean delivery, there was no difference in wound infection, but there was a higher incidence of wound separation in the group that had a seroma (7.4% vs. 1.9%, p = 0.019). Conclusion: In this cohort, one-third of patients undergoing OMFS developed seroma with no associated change in wound healing or prenatal course. Risk factors included older maternal age and increased BMI. The majority were small and resolved, without intervention, prior to delivery. Following cesarean delivery, there was an increased rate of wound separation in patients who previously had postoperative seroma.
- 22 January 2026
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 53 (4) , 1-8
Open AccessMaternal Subcutaneous Seroma following Open Maternal Fetal Surgery for Closure of Fetal Open Neural Tube Defects
Introduction: Maternal seroma has been noted following open maternal fetal surgery (OMFS) for fetal neural tube defect (fNTD) closure but the risk factors, timing of diagnosis, natural course, and clinical significance have not been reported. Methods: Retrospective review of 340 patients who underwent OMFS for fNTD at a single center. Archived postoperative ultrasound images were reviewed and seroma details on serial ultrasound imaging were recorded. Perioperative characteristics and delivery outcomes were then compared in patients that did or did not develop a maternal seroma after OMFS. Multivariable logistic regression was performed to identify risk factors for seroma formation. Results: Of 330 patients with ongoing pregnancies at least 10 days after OMFS, 122 (37%) patients had sonographic evidence of seroma. Median postoperative day at diagnosis was 11 with median time to resolution of 21 days. Median longest diameter at diagnosis was 5.23 cm with a median initial volume of 9.66 mL. Seromas minimally increased in size prior to resolution. Multivariable logistic regression identified increasing maternal age and body mass index (BMI) as statistically significant risk factors for seroma formation (OR 1.08 and 1.17, respectively). There was no difference in the incidence of post-OMFS complications in those who developed seroma and those who did not, including no difference in the rate of membrane separation, oligohydramnios, preterm premature rupture of membranes, placental abruption, preterm labor, gestational age at delivery, fetal demise, or hysterotomy dehiscence. Following cesarean delivery, there was no difference in wound infection, but there was a higher incidence of wound separation in the group that had a seroma (7.4% vs. 1.9%, p = 0.019). Conclusion: In this cohort, one-third of patients undergoing OMFS developed seroma with no associated change in wound healing or prenatal course. Risk factors included older maternal age and increased BMI. The majority were small and resolved, without intervention, prior to delivery. Following cesarean delivery, there was an increased rate of wound separation in patients who previously had postoperative seroma.
- 19 January 2026
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 53 (4) , 1-13
Outcome of Prenatally Diagnosed Fetal Liver Lesions: Implications for Prenatal Management
Introduction: The aim of this study was to evaluate the diagnostic yield of prenatal imaging for fetal liver lesions and to characterize associated postnatal outcomes. Methods: We conducted a single-center retrospective review of prenatally diagnosed liver lesions between 2013 and 2023. Data collected included prenatal imaging findings, postnatal diagnoses, neonatal outcomes, and management strategies. Results: Thirty women were referred at a median gestational age (GA) of 31.1 weeks [IQR: 27.5–33.4]. Lesions were classified as cystic (53%), solid (20%), mixed (17%), or vascular (10%). Postnatal diagnoses included hemangioma (33%), hepatic cyst (27%), choledochal cyst (10%), arteriovenous malformation or portosystemic shunt (13%), mesenchymal hamartoma (7%), biliary atresia (3%), focal nodular hyperplasia (3%), and unknown (6%). Overall diagnostic concordance between prenatal and postnatal findings was 69%. Fetal complications occurred in 40% of cases, most commonly cardiac overload (n = 8), intrauterine growth restriction (n = 3), and mass effect (n = 2). Hypervascularized lesions were significantly associated with fetal compromise (p < 0.001). No cases of intrauterine fetal demise were observed. Fetal MRI was performed in 70% of cases and improved diagnostic accuracy in two cases. Median GA at delivery was 38.0 weeks [IQR: 36.6–39.1]. Postnatal management included expectant observation (67%), surgery (20%), β-blockers (7%), and embolization (3%). After a median follow-up of 32.5 months [IQR: 14.8–60.9], 38% of lesions had regressed spontaneously. One infant died from complications following embolization. Conclusion: Most fetal liver lesions are associated with favorable outcomes. However, hypervascularized lesions are predictive of in utero complications and warrant close monitoring. Fetal MRI may improve diagnostic accuracy and guide postnatal management.
- 19 January 2026
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 53 (4) , 1-13
Outcome of Prenatally Diagnosed Fetal Liver Lesions: Implications for Prenatal Management
Introduction: The aim of this study was to evaluate the diagnostic yield of prenatal imaging for fetal liver lesions and to characterize associated postnatal outcomes. Methods: We conducted a single-center retrospective review of prenatally diagnosed liver lesions between 2013 and 2023. Data collected included prenatal imaging findings, postnatal diagnoses, neonatal outcomes, and management strategies. Results: Thirty women were referred at a median gestational age (GA) of 31.1 weeks [IQR: 27.5–33.4]. Lesions were classified as cystic (53%), solid (20%), mixed (17%), or vascular (10%). Postnatal diagnoses included hemangioma (33%), hepatic cyst (27%), choledochal cyst (10%), arteriovenous malformation or portosystemic shunt (13%), mesenchymal hamartoma (7%), biliary atresia (3%), focal nodular hyperplasia (3%), and unknown (6%). Overall diagnostic concordance between prenatal and postnatal findings was 69%. Fetal complications occurred in 40% of cases, most commonly cardiac overload (n = 8), intrauterine growth restriction (n = 3), and mass effect (n = 2). Hypervascularized lesions were significantly associated with fetal compromise (p < 0.001). No cases of intrauterine fetal demise were observed. Fetal MRI was performed in 70% of cases and improved diagnostic accuracy in two cases. Median GA at delivery was 38.0 weeks [IQR: 36.6–39.1]. Postnatal management included expectant observation (67%), surgery (20%), β-blockers (7%), and embolization (3%). After a median follow-up of 32.5 months [IQR: 14.8–60.9], 38% of lesions had regressed spontaneously. One infant died from complications following embolization. Conclusion: Most fetal liver lesions are associated with favorable outcomes. However, hypervascularized lesions are predictive of in utero complications and warrant close monitoring. Fetal MRI may improve diagnostic accuracy and guide postnatal management.
- 22 June 2025
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 41 (1) , 34-42
Agenesis of Corpus Callosum: A Clinical Study of Complete Versus Partial Agenesis in a 20-Year Retrospective Cohort
Agenesis of the corpus callosum (ACC) has a wide spectrum of anatomic manifestations associated with incompletely understood clinical variability. In this retrospective cohort study, 161 children with ACC were classified into complete ACC and partial ACC. Partial and complete ACC diagnoses were confirmed by postnatal magnetic resonance imaging (MRI) and further classified as isolated or complex (associated with other brain abnormalities or genetic diagnoses). Clinical characteristics, clinical outcomes, and co-occurring genetic variations were collected by chart review. Median age at last neurologic evaluation for the complete and partial ACC cohorts were 2.8 years and 2.3 years, respectively; thus, an average of 2-3 years of follow-up data were analyzed per patient. Results showed that children with complete and partial ACC had similar birth characteristics. Children with complete ACC were more frequently diagnosed prenatally; additionally, complete ACC patients had lower rates of cerebral palsy. When comparing complex complete ACC and complex partial ACC to isolated complete ACC and isolated partial ACC, respectively, the complex subcohorts had a higher level of motor delay, assistive device use, cerebral palsy, ventriculoperitoneal shunt placement, epilepsy, language delay, and cognitive delay than the isolated subcohorts. About 50% of children had genetic variants associated with neurodevelopmental disorders in this cohort. Additionally, >50% of our patients with motor and nonmotor developmental delays, as well as >60% of patients that required assistive devices and had cerebral palsy, were also found to have genetic anomalies. Although research describing ACC and its outcomes is expanding, there is still a need for large cohort studies with robust follow-up data to help further understand the disease.
- 22 June 2025
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 41 (1) , 34-42
Agenesis of Corpus Callosum: A Clinical Study of Complete Versus Partial Agenesis in a 20-Year Retrospective Cohort
Agenesis of the corpus callosum (ACC) has a wide spectrum of anatomic manifestations associated with incompletely understood clinical variability. In this retrospective cohort study, 161 children with ACC were classified into complete ACC and partial ACC. Partial and complete ACC diagnoses were confirmed by postnatal magnetic resonance imaging (MRI) and further classified as isolated or complex (associated with other brain abnormalities or genetic diagnoses). Clinical characteristics, clinical outcomes, and co-occurring genetic variations were collected by chart review. Median age at last neurologic evaluation for the complete and partial ACC cohorts were 2.8 years and 2.3 years, respectively; thus, an average of 2-3 years of follow-up data were analyzed per patient. Results showed that children with complete and partial ACC had similar birth characteristics. Children with complete ACC were more frequently diagnosed prenatally; additionally, complete ACC patients had lower rates of cerebral palsy. When comparing complex complete ACC and complex partial ACC to isolated complete ACC and isolated partial ACC, respectively, the complex subcohorts had a higher level of motor delay, assistive device use, cerebral palsy, ventriculoperitoneal shunt placement, epilepsy, language delay, and cognitive delay than the isolated subcohorts. About 50% of children had genetic variants associated with neurodevelopmental disorders in this cohort. Additionally, >50% of our patients with motor and nonmotor developmental delays, as well as >60% of patients that required assistive devices and had cerebral palsy, were also found to have genetic anomalies. Although research describing ACC and its outcomes is expanding, there is still a need for large cohort studies with robust follow-up data to help further understand the disease.
- 18 June 2025
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 52 (6) , 604-609
Development of a Postpartum Follow-Up Program in a Fetal Center
Introduction: Patients delivering in a highly specialized fetal center often travel a distance from their homes and primary care providers, leaving the potential for significant gaps in comprehensive postpartum care. The objective of the study was to evaluate the implementation, engagement, and outcomes of a nurse-led postpartum follow-up program during its first year of inception. Methods: A registered nurse conducted outreach via phone, text, or email at 2–3 and 6–8 weeks postpartum for all patients who delivered in a special delivery unit of a children’s hospital. Standardized scripts included medical and mental health concerns to assess engagement, postpartum complications, care utilization, contraception use, lactation, and follow-up completion. Results: Of 407 patients, 503 total outreach calls were completed. The engagement rate was high, with contact established for 89.9% of participants. At least one clinical concern was identified in over 25% of patients, prompting further follow-up. Only 1.7% required readmission and 94.3% visited an emergency department, rates comparable to national postpartum benchmarks. At 6–8 weeks, 75% had attended or scheduled a postpartum visit. Contraception use was reported by 65% of patients, and 67% reported active lactation. Mental health screening flagged 6.4% of patients, with a significantly higher rate (26.5%) among those who experienced fetal or neonatal loss compared to those who did not (4.3%, p < 0.00001). Conclusion: The implementation of a comprehensive nurse-led postpartum program in a fetal therapy center achieved a high engagement rate and demonstrated feasibility and value in bridging care gaps supporting the expansion of telehealth-based postpartum follow-up in fetal therapy centers.
- 18 June 2025
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 52 (6) , 604-609
Development of a Postpartum Follow-Up Program in a Fetal Center
Introduction: Patients delivering in a highly specialized fetal center often travel a distance from their homes and primary care providers, leaving the potential for significant gaps in comprehensive postpartum care. The objective of the study was to evaluate the implementation, engagement, and outcomes of a nurse-led postpartum follow-up program during its first year of inception. Methods: A registered nurse conducted outreach via phone, text, or email at 2–3 and 6–8 weeks postpartum for all patients who delivered in a special delivery unit of a children’s hospital. Standardized scripts included medical and mental health concerns to assess engagement, postpartum complications, care utilization, contraception use, lactation, and follow-up completion. Results: Of 407 patients, 503 total outreach calls were completed. The engagement rate was high, with contact established for 89.9% of participants. At least one clinical concern was identified in over 25% of patients, prompting further follow-up. Only 1.7% required readmission and 94.3% visited an emergency department, rates comparable to national postpartum benchmarks. At 6–8 weeks, 75% had attended or scheduled a postpartum visit. Contraception use was reported by 65% of patients, and 67% reported active lactation. Mental health screening flagged 6.4% of patients, with a significantly higher rate (26.5%) among those who experienced fetal or neonatal loss compared to those who did not (4.3%, p < 0.00001). Conclusion: The implementation of a comprehensive nurse-led postpartum program in a fetal therapy center achieved a high engagement rate and demonstrated feasibility and value in bridging care gaps supporting the expansion of telehealth-based postpartum follow-up in fetal therapy centers.
- 11 March 2025
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 52 (4) , 402-411
Risk Factors for Spontaneous Preterm Delivery in Monochorionic Diamniotic Pregnancies Undergoing Selective Fetal Reduction via Radiofrequency Ablation
Introduction: To identify risk factors for spontaneous preterm delivery (sPTD) before 32, 34, and 37 weeks in a cohort of monochorionic diamniotic (MCDA) twin pregnancies undergoing selective fetal reduction (SFR) using radiofrequency ablation (RFA). Methods: A single-center retrospective analysis of complex MCDA twin pregnancies managed with SFR via RFA between 2014 and 2023. Perioperative variables were compared between patients who had sPTD before and after 34 weeks and 37 weeks. We also compared variables for pregnancies that were delivered before and after 32 weeks. Correlation analysis between gestational age at SFR and gestational age at delivery was performed. A Kaplan-Meier survival analysis was created for time to 34 weeks grouped by different diagnostic indications and a log-rank test was performed. Results: In the study cohort, the total rate of preterm delivery was 52.0% of these 46.9% pregnancies delivering spontaneously. The rate of sPTD before 34 weeks was 27.1% and before 32 weeks was 19.4%. There was a significantly higher proportion of pregnancies undergoing RFA for the indication of TTTS that delivered before 34 weeks (43.5% vs. 22.6%, p = 0.01). Also, a greater number of pregnancies undergoing RFA for the indication of TTTS delivered before 37 weeks spontaneously (35.7% vs. 20.9%, p = 0.04). A subgroup analysis of sPTD before 32 weeks was performed. Preoperative cervical length was the only independent predictor for delivery before 32 weeks on multiple regression after controlling for confounders. Gestational age at procedure did not correlate with gestational age at delivery (p = 0.78). Kaplan-Meier curves showed that the proportion of pregnancies remaining undelivered from the time of RFA until 34 weeks’ gestation was lower for the indication of TTTS. Conclusion: Preoperative indication of TTTS was associated with an increased risk of sPTD before 34 and 37 weeks in the MCDA twin population undergoing RFA. In contrast, preoperative cervical length was independently associated with sPTD before 32 weeks in the same population.
- 11 March 2025
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 52 (4) , 402-411
Risk Factors for Spontaneous Preterm Delivery in Monochorionic Diamniotic Pregnancies Undergoing Selective Fetal Reduction via Radiofrequency Ablation
Introduction: To identify risk factors for spontaneous preterm delivery (sPTD) before 32, 34, and 37 weeks in a cohort of monochorionic diamniotic (MCDA) twin pregnancies undergoing selective fetal reduction (SFR) using radiofrequency ablation (RFA). Methods: A single-center retrospective analysis of complex MCDA twin pregnancies managed with SFR via RFA between 2014 and 2023. Perioperative variables were compared between patients who had sPTD before and after 34 weeks and 37 weeks. We also compared variables for pregnancies that were delivered before and after 32 weeks. Correlation analysis between gestational age at SFR and gestational age at delivery was performed. A Kaplan-Meier survival analysis was created for time to 34 weeks grouped by different diagnostic indications and a log-rank test was performed. Results: In the study cohort, the total rate of preterm delivery was 52.0% of these 46.9% pregnancies delivering spontaneously. The rate of sPTD before 34 weeks was 27.1% and before 32 weeks was 19.4%. There was a significantly higher proportion of pregnancies undergoing RFA for the indication of TTTS that delivered before 34 weeks (43.5% vs. 22.6%, p = 0.01). Also, a greater number of pregnancies undergoing RFA for the indication of TTTS delivered before 37 weeks spontaneously (35.7% vs. 20.9%, p = 0.04). A subgroup analysis of sPTD before 32 weeks was performed. Preoperative cervical length was the only independent predictor for delivery before 32 weeks on multiple regression after controlling for confounders. Gestational age at procedure did not correlate with gestational age at delivery (p = 0.78). Kaplan-Meier curves showed that the proportion of pregnancies remaining undelivered from the time of RFA until 34 weeks’ gestation was lower for the indication of TTTS. Conclusion: Preoperative indication of TTTS was associated with an increased risk of sPTD before 34 and 37 weeks in the MCDA twin population undergoing RFA. In contrast, preoperative cervical length was independently associated with sPTD before 32 weeks in the same population.
- 1 January 2025
- Published by Wiley in Prenatal Diagnosis
- Vol. 45 (3) , 310-317
Whole Exome Sequencing in a Population of Fetuses With Structural Anomalies
Objective: To investigate the exome sequencing (ES) detection rate among fetuses with congenital anomalies and describe the rates in the setting of multiple versus isolated anomalies, perinatal autopsy, and family history of a previously affected child.Methods: A single‐center retrospective chart review was conducted on 397 anomalous fetuses that underwent ES from May 2012 through December 2023. Medical record review included demographics, imaging, and genetic testing.Results: The overall ES diagnostic rate was 34.3%. The rate of diagnosis was 31.6% in fetuses with a single anomaly and 42.6% in fetuses with 4 or more major organ systems involved. Of the fetuses with a single anomaly, lymphatic, craniofacial, skeletal, and neurological anomalies had the highest diagnostic rate on ES. 38.6% of deceased fetuses who underwent autopsy had a genetic diagnosis. Additionally, families who had a previously affected child had a 45.5% diagnostic rate.Conclusions: ES is an important tool that should be offered in pregnancies affected with congenital abnormalities or at the time of fetal demise or termination. The diagnostic rate of ES in the prenatal setting is also highly dependent on comprehensive phenotyping. With diagnostic ES results, reproductive technology and testing options are available in subsequent pregnancies.
- 1 January 2025
- Published by Wiley in Prenatal Diagnosis
- Vol. 45 (3) , 310-317
Whole Exome Sequencing in a Population of Fetuses With Structural Anomalies
Objective: To investigate the exome sequencing (ES) detection rate among fetuses with congenital anomalies and describe the rates in the setting of multiple versus isolated anomalies, perinatal autopsy, and family history of a previously affected child.Methods: A single‐center retrospective chart review was conducted on 397 anomalous fetuses that underwent ES from May 2012 through December 2023. Medical record review included demographics, imaging, and genetic testing.Results: The overall ES diagnostic rate was 34.3%. The rate of diagnosis was 31.6% in fetuses with a single anomaly and 42.6% in fetuses with 4 or more major organ systems involved. Of the fetuses with a single anomaly, lymphatic, craniofacial, skeletal, and neurological anomalies had the highest diagnostic rate on ES. 38.6% of deceased fetuses who underwent autopsy had a genetic diagnosis. Additionally, families who had a previously affected child had a 45.5% diagnostic rate.Conclusions: ES is an important tool that should be offered in pregnancies affected with congenital abnormalities or at the time of fetal demise or termination. The diagnostic rate of ES in the prenatal setting is also highly dependent on comprehensive phenotyping. With diagnostic ES results, reproductive technology and testing options are available in subsequent pregnancies.